// App-Quantinova.ai

: Subthreshold laser compared to spironolactone in treatment of chronic central serous retinopathy

Researchers

Presenter

  • Stefano Mercuri

Principal Investigators

  • Paolo Corazza

  • Nancy Khairat

  • Saad Younis

Medical Centers

  • Western Eye Hospital Imperial College Healthcare NHS Trust, Glaucoma, London, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Diabetic retinopathy

Biomarkers

  • Scavenger Receptor Class A Member 3

Drug/Treatment

  • Spironolactone

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved